PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))

Term ID

CHEBI:88911

Synonyms

(2-{[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Eicsoate
1-Eicsoatetraenoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine
1-Eicsoic acid
GPCho(20:4/16:1)
GPCho(20:4n3/16:1n7)
GPCho(20:4w3/16:1w7)
GPCho(36:5)
Lecithin
PC aa C36:5
PC(20:4/16:1)
PC(20:4n3/16:1n7)
PC(20:4w3/16:1w7)
PC(36:5)
Phosphatidylcholine(20:4/16:1)
Phosphatidylcholine(20:4n3/16:1n7)
Phosphatidylcholine(20:4w3/16:1w7)
Phosphatidylcholine(36:5)

(all 18)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))

Phenotype where environments contain PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))

Phenotype modified by environments containing PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))

Phenotype affecting PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))

Human Disease Model